Leflunomide
CAS: 75706-12-6
Rif. IN-DA005IU1
1g | Fuori produzione | ||
5g | Fuori produzione | ||
25g | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Leflunomide
Sinonimi:
- [u'Arava', u'HWA 486', u'HWA-486', u'HWA486', u'N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide', u'SU101', u'75706-12-6', u'Arava', u'Leflunomidum', u'lefunamide', u'Leflunomida', u'HWA 486', u'Leflunomidum [INN-Latin]', u'HWA-486', u'5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide', u'Leflunomida [INN-Spanish]', u'SU 101 (pharmaceutical)', u'Arava (TN)', u'Lefunomide [Inn-Spanish]', u'SU101', u'5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide', u'5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide', u'UNII-G162GK9U4W', u'SU-101', u'5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide', u'5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide', u'4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-', u'alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide', u'HSDB 7289', u'CHEMBL960', u'RS-34821', u'MLS000069648', u'CHEBI:6402', u'G162GK9U4W', u"N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide", u'5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)', u'MFCD00867593', u'NCGC00015610-02', u'SMR000058209', u'5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide', u'4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-', u'CAS-75706-12-6', u'DSSTox_CID_3201', u'DSSTox_RID_76923', u'DSSTox_GSID_23201', u'Leflunomid', u'Repso', u'Leflunomide [USAN:INN]', u'SR-01000000191', u'Lefunomide', u'Arabloc', u'Leflunomide (JAN/USAN/INN)', u'HWA486', u'Prestwick_87', u'Leflunomide [USAN:USP:INN:BAN]', u'SU 101', u'SULOL', u'N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide', u'Spectrum_000322', u'AC1L1GYK', u'AC1Q2EVA', u'Opera_ID_1709', u'Prestwick0_000772', u'Prestwick1_000772', u'Prestwick2_000772', u'Prestwick3_000772', u'Spectrum5_000850', u'Lopac-L-5025', u'L 5025', u'SCHEMBL5057', u'BIDD:PXR0189', u'Lopac0_000649', u'BSPBio_000844', u'KBioSS_000802', u'Leflunomide, Immunosuppressant', u'MLS001076267', u'DivK1c_000916', u'SPECTRUM1503927', u'5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide', u'SPBio_002783', u'BPBio1_000930', u'GTPL6825', u'ISO054', u'ZINC4840', u'DTXSID9023201', u'CTK8G0535', u'HMS502N18', u'KBio1_000916', u'KBio2_000802', u'KBio2_003370', u'KBio2_005938', u'KS-00000KQI', u'AOB5964', u'NINDS_000916', u'VHOGYURTWQBHIL-UHFFFAOYSA-N', u'4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl', u'4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)', u'5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid', u'HMS1570K06', u'HMS1922M06', u'HMS2090O12', u'HMS2097K06', u'HMS2235C07', u'HMS3262A19', u'HMS3268D12', u'HMS3371F21', u'HMS3654F07', u'HMS3678N21', u'HMS3714K06', u'Pharmakon1600-01503927', u'ALBB-019233', u'BCP22241', u'EBD46417', u'HY-B0083', u'Tox21_110182', u'Tox21_301873', u'Tox21_500649', u'ABP001076', u'BDBM50054601', u'DL-433', u'NSC677411', u'NSC759864', u's1247', u'STL426823', u'AKOS000265193', u'Tox21_110182_1', u'AC-6796', u'AN-9632', u'BCP9000846', u'CCG-204736', u'CS-1781', u'DB01097', u'KS-1076', u'LP00649', u'MCULE-9490869974', u'NSC-677411', u'NSC-759864', u'RP29613', u'SB17287', u'IDI1_000916', u'NCGC00015610-01', u'NCGC00015610-03', u'NCGC00015610-04', u'NCGC00015610-05', u'NCGC00015610-06', u'NCGC00015610-07', u'NCGC00015610-08', u'NCGC00015610-09']
- 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
- 5-Methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
- 5-Methylisoxazole-4-Carboxylic Acid (4-Trifluoromethyl)Anilide
- 5-methyl-N-[4-(trifluoromethyl) phenyl]-isoxazole-4-carboxamide
- 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazole carboxamide
- Alpha,Alpha,Alpha-Trifluoro-5-Methyl-4-Isoxazolecarboxy-P-Toluidide
- Arava
- Avara
- Cleft
- Vedi altri sinonimi
- Hwa 486
- Hwa486
- Leflunomida
- Leflunomidum
- Lefumide
- N-(4-trifluoromethylphenyl)-5-methylisoxazol-4-carboxamide
- Repso
- Rs-34821
- SU 101 (pharmaceutical)
- Su 101
- alfa-alfa-alfa-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidine
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
270.2073
Formula:
C12H9F3N2O2
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)
InChI key:
VHOGYURTWQBHIL-UHFFFAOYSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA: